NCT01213368 - Dose Ranging Study of Dronedarone for the Control of Ventricular Rate in Japanese Patients With Permanent Atrial Fibrillation | Biotech Hunter

Enrollment

181

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions

Atrial Fibrillation

Interventions

DRUG

DRONEDARONE (SR33589)

"Pharmaceutical form: tablets~Route of administration: oral"

DRUG

placebo

"Pharmaceutical form: tablets~Route of administration: oral"

Trial Locations (25)

Investigational Site Number 392022, Hiroshima

Investigational Site Number 392018, Kagoshima

Investigational Site Number 392005, Kasama-Shi

Investigational Site Number 392014, Kawanishi-Shi

Investigational Site Number 392008, Kawasaki-Shi

Investigational Site Number 392007, Kisarazu-Shi

Investigational Site Number 392012, Kobe

Investigational Site Number 392013, Kobe

Investigational Site Number 392003, Koriyama-Shi

Investigational Site Number 392017, Kurume-Shi

Investigational Site Number 392023, Miyazaki

Investigational Site Number 392009, Nagano

Investigational Site Number 392019, Nagasaki

Investigational Site Number 392010, Osaka

Investigational Site Number 392021, Sapporo

Investigational Site Number 392025, Sapporo

Investigational Site Number 392002, Sendai

Investigational Site Number 392004, Shirakawa-Shi

Investigational Site Number 392016, Shunan-Shi

Investigational Site Number 392020, Suwa-Shi

Investigational Site Number 392006, Takasaki-Shi

Investigational Site Number 392001, Tomakomai-Shi

Investigational Site Number 392024, Toshima-Ku

Investigational Site Number 392015, Ube-Shi

Investigational Site Number 392011, Yakushi